The first PDL Biopharma trade was made in Q1 2008.
Since then Seth Klarman bought shares six more times and sold shares on five occasions. The investor completely sold their stake between Q4 2011 and Q1 2012.
Avg closing price
Price range
Sold -8 Million shares
Q1 2012
Avg closing price
$5.91
Price range
$5.63
-
$6.15
Sold 48.8% shares (-7.64 Million shares)
Q4 2011
Avg closing price
$5.59
Price range
$5.00
-
$5.99
Increased shares by 68.8% (+6.37 Million shares)
Q3 2011
Avg closing price
$5.51
Price range
$5.12
-
$5.98
Sold 11.7% shares (-1.23 Million shares)
Q2 2011
Avg closing price
$5.82
Price range
$5.37
-
$6.21
Increased shares by 87.3% (+4.89 Million shares)
Q1 2011
Avg closing price
$5.01
Price range
$4.39
-
$5.95
New holding (+5.6 Million shares)
Q4 2010
Avg closing price
$5.36
Price range
$4.82
-
$6.09
Sold 18.7% shares (-2.9 Million shares)
Q2 2009
Avg closing price
$6.79
Price range
$6.14
-
$7.44
Increased shares by 8.3% (+1.2 Million shares)
Q1 2009
Avg closing price
$5.95
Price range
$4.88
-
$6.68
Increased shares by 3.6% (+503 Thousand shares)
Q4 2008
Avg closing price
$8.23
Price range
$5.48
-
$9.50
Sold 6.5% shares (-965 Thousand shares)
Q3 2008
Avg closing price
$10.28
Price range
$8.39
-
$11.73
Increased shares by 3111.7% (+14.4 Million shares)
Q2 2008